A Study of HDM2024 in Participants With Advanced Solid Tumors

NCT07539285 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: HDM2024

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.